Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

The effect of oral galactose on glucose homeostasis and memory in a transgenic mice model of familial Alzheimer's disease (CROSBI ID 665480)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa

Babić, Ana ; Osmanović Barilar, Jelena ; Knezović, Ana ; Bagarić, Robert ; Farkaš, Vladimir ; Riederer, Peter ; Šalković-Petrišić, Melita The effect of oral galactose on glucose homeostasis and memory in a transgenic mice model of familial Alzheimer's disease // 11th FENS Forum of Neuroscience Abstracts. 2018. str. 4102-4102

Podaci o odgovornosti

Babić, Ana ; Osmanović Barilar, Jelena ; Knezović, Ana ; Bagarić, Robert ; Farkaš, Vladimir ; Riederer, Peter ; Šalković-Petrišić, Melita

engleski

The effect of oral galactose on glucose homeostasis and memory in a transgenic mice model of familial Alzheimer's disease

AIMS: Decreased glucose metabolism and energy in the brain accompanies sporadic Alzheimer’s disease (sAD). Our recent research revealed that oral galactose, an alternative source of energy, successfully prevented the development/normalized early-developed cognitive deficits in a nontransgenic sAD rat model. We aimed to explore whether oral galactose has therapeutic effects on cognitive deficits in transgenic mice model of familial AD. METHODS: 80 male transgenic Tg2576 (WT/TG) and wild-type (WT/WT) mice aged 5 and 10 months underwent 2-month drink of oral galactose solution (+GAL) or tap water. Morris Water Maze (MWM), intraperitoneal glucose tolerance test, and fluorodeoxyglucose Positron-Emission- Tomography (PET) scanning were performed before sacrifice. RESULTS: MWM showed no deficits in 7-month but significant (p=0.029) cognitive decline in 12- month aged WT/TG mice compared to their respective WT/WT controls (-75%/probe trial) associated with markedly decreased movement pattern which worsened by galactose treatment in WT/WT and WT/TG groups. PET scans demonstrated increased (+19.65%) and decreased (-17.70%) glucose uptake/metabolism in the whole brain of 7- and 12-month aged WT/TG mice, which were normalized by galactose (decreased -13.90%/7-month and increased +32.09%/12-month aged WT/TG+GAL mice) respectively. Compared to WT/WT, WT/TG group showed impaired glucose tolerance only at 12- months (glucose level increased +16 to +72%) further worsened by galactose treatment (additional +21 to +51% increment, p<0.05). Galactose treatment had no effects in 12-month aged WT/WT group but lowered glucose levels in 7-month old group (-32 to -45%). CONCLUSION: Oral galactose worsens peripheral but improves central glucose homeostasis without affecting memory in cognitively impaired transgenic AD mice. Supported by HRZZ-IP-09-2014-4639.

Alzheimer's disease ; galactose ; metabolism ; trangenic mice ; cognition

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

4102-4102.

2018.

objavljeno

Podaci o matičnoj publikaciji

11th FENS Forum of Neuroscience Abstracts

Podaci o skupu

11th FENS Forum of Neuroscience

poster

07.07.2018-11.07.2018

Berlin, Njemačka

Povezanost rada

Farmacija

Poveznice